Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Secondary pulmonary hemosiderosis is a respiratory disease due to the deposition of hemosiderin-laden macrophages in lungs as a result of repeated alveolar hemorrhage secondary to another disease, especially dysimmunitary disorders (i.e. Heiner syndrome, autoimmune diseases), thrombotic disorders and cardiovascular disorders such as mitral stenosis. It manifests as a triad of hemoptysis, anemia and diffuse parenchymal infiltrates on chest radiography
Biomarker and diagnostic research for secondary pulmonary hemosiderosis has been reported in the published literature.
No clinical trials have been registered for secondary pulmonary hemosiderosis.
7 publications have been identified in PubMed for secondary pulmonary hemosiderosis. Research spans Case Report / Case Series (29%), Epidemiology / Natural History (29%), and Diagnostic / Biomarker (14%).
Shah P (2026). [PMID: 41513509](https://pubmed.ncbi.nlm.nih.gov/41513509/). *Seminars in roentgenology*. [Diagnostic / Biomarker]
Varon-Vega F (2026). [PMID: 41953042](https://pubmed.ncbi.nlm.nih.gov/41953042/). *Case Rep Pathol*. [Case Report / Case Series]
LaFreniere K (2026). [PMID: 32644388](https://pubmed.ncbi.nlm.nih.gov/32644388/). *Unknown Journal*. [Review / Meta-Analysis]
Moore SA (2026). [PMID: 41765695](https://pubmed.ncbi.nlm.nih.gov/41765695/). *The American journal of surgical pathology*. [Basic Science / Preclinical]
J R (2025). [PMID: 40755652](https://pubmed.ncbi.nlm.nih.gov/40755652/). *Cureus*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 11:14 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Li S (2025). [PMID: 40949900](https://pubmed.ncbi.nlm.nih.gov/40949900/). *Translational pediatrics*. [Epidemiology / Natural History]
AI-curated news mentioning secondary pulmonary hemosiderosis
Updated Apr 7, 2026
A case report details successful bilateral lung transplantation in a patient with lymphangioleiomyomatosis complicated by secondary pulmonary hemosiderosis. This study contributes to the understanding of treatment options for this rare lung disease.